Vote Scores
Filings read through

West Pharmaceutical Services, Inc.: how funds voted at the meeting of 4 May 2026

Ticker
WST
Meeting
Season
year to 30 June 2026
Filers reporting
904
Ballot items
5

904 filers on Form N-PX reported votes at the West Pharmaceutical Services, Inc. meeting of 4 May 2026. The records fall into 5 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    11 nominees. 94.0% of the reported votes are for. 27 filers withheld from or voted against at least one nominee.

    7,551 vote records from 248 filers. 4 of the 247 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 50 fund families
    • For 50
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1,505 vote records from 899 filers. 58 of the 870 filers that marked the item voted against management. 29 filers gave no management mark.

    • Positions of 53 fund families
    • For 53
  3. Item 3: Audit-related items (auditor ratification)

    685 vote records from 247 filers. 4 of the 246 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 50 fund families
    • For 50
  4. Item 4: Shareholder proposal regarding an independent Board Chair policy.

    665 vote records from 242 filers. 126 of the 241 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 50 fund families
    • For 29
    • Against 21
    • Against management 30
  5. Item 5: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    1 vote record from 1 filer. 1 of the 1 filer that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at West Pharmaceutical Services, Inc., meeting of 4 May 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor4. Proposal
AllianceBernsteinForForFor, against management
AllspringForForFor, against management
American CenturyForForAgainst
Artisan PartnersForForAgainst
BairdForForFor, against management
BlackRock and iSharesForForAgainst
BNY MellonForForAgainst
Brighthouse FundsForForFor, against management
Capital Group and American FundsForForFor, against management
Charles SchwabForForAgainst
Columbia ThreadneedleForForFor, against management
DimensionalForForAgainst
DWSForForFor, against management
EquitableForForFor, against management
Federated HermesForForFor, against management
FidelityForForAgainst
First TrustForForFor, against management
Franklin TempletonForForFor, against management
Global XForForFor, against management
Goldman SachsForForAgainst
Guggenheim and RydexForForFor, against management
Hartford FundsForForFor, against management
InvescoForForFor, against management
J.P. MorganForForAgainst
Jackson National fundsForForFor, against management
Janus HendersonForNo reportNo report
John Hancock and ManulifeForForAgainst
Lincoln FinancialForForAgainst, against management
Macquarie and Delaware FundsForNo reportNo report
MassMutualForForFor, against management
Morgan Stanley, Eaton Vance and CalvertForForFor, against management
NationwideForForFor, against management
Natixis and Loomis SaylesForNo reportNo report
Neuberger BermanForForFor, against management
Northern Trust and FlexSharesForForAgainst
Nuveen and TIAAForForAgainst
Pacific Life fundsForForAgainst
PGIM and PrudentialForForFor, against management
PIMCOForForFor, against management
PrincipalForForAgainst
ProShares and ProFundsForForFor, against management
Russell InvestmentsForForFor, against management
SEIForForFor, against management
State Street and SPDRForForAgainst
T. Rowe PriceForForFor, against management
ThriventForForAgainst
TransamericaForForAgainst
VanEckForForFor, against management
VanguardForForAgainst
Victory CapitalForForFor, against management
VirtusForForFor, against management
VoyaForForAgainst
WisdomTreeForForAgainst

Questions

How many filers reported votes at the West Pharmaceutical Services, Inc. meeting?
904 Form N-PX filers reported votes at the meeting of 4 May 2026. On say-on-pay, 58 of 870 filers that marked the item voted against management (6.7%). The filings show one separate proposal from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. West Pharmaceutical Services, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list West Pharmaceutical Services, Inc. with a meeting date within three days of 4 May 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .